Nevro Corp NVRO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Nevro Announces the Launch of HFX AdaptivAI™, the Only AI-Driven Technology in Spinal Cord Stimulation
-
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
-
Nevro to Present at Wells Fargo 2024 Healthcare Conference
-
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
-
Nevro Reports Second-Quarter 2024 Financial Results
-
Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08
-
Nevro to Report Second-Quarter 2024 Financial Results and Host Earnings Conference Call on August 6, 2024
-
Nevro laying off 63 employees; revenue to beat analyst estimates
Trading Information
- Previous Close Price
- $4.95
- Day Range
- $4.81–5.13
- 52-Week Range
- $4.38–22.64
- Bid/Ask
- $4.87 / $5.07
- Market Cap
- $185.30 Mil
- Volume/Avg
- 272,030 / 664,607
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.43
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,215
- Website
- https://www.nevro.com
Comparables
Valuation
|
Metric
|
NVRO
|
SIBN
|
LMAT
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 54.86 |
Price/Book Value | 0.67 | 3.70 | 6.44 |
Price/Sales | 0.43 | 3.97 | 10.05 |
Price/Cash Flow | — | — | 36.06 |
Price/Earnings
NVRO
SIBN
LMAT
Financial Strength
|
Metric
|
NVRO
|
SIBN
|
LMAT
|
|---|---|---|---|
Quick Ratio | 3.41 | 7.99 | 5.66 |
Current Ratio | 4.77 | 9.17 | 8.36 |
Interest Coverage | −4.43 | −12.97 | — |
Quick Ratio
NVRO
SIBN
LMAT
Profitability
|
Metric
|
NVRO
|
SIBN
|
LMAT
|
|---|---|---|---|
Return on Assets (Normalized) | −4.60% | −6.03% | 12.82% |
Return on Equity (Normalized) | −9.56% | −8.10% | 14.75% |
Return on Invested Capital (Normalized) | −4.84% | −8.97% | 12.97% |
Return on Assets
NVRO
SIBN
LMAT
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Ybvrtphv | Xllbcy | $196.0 Bil | |||
| Stryker Corp
SYK
| Hgtjbqtd | Jpl | $133.8 Bil | |||
| Boston Scientific Corp
BSX
| Ljwgwqrzr | Tyfsgq | $124.5 Bil | |||
| Medtronic PLC
MDT
| Hlzqcms | Hnlhtxl | $113.2 Bil | |||
| Edwards Lifesciences Corp
EW
| Hvbkrpqq | Bsmfpq | $39.5 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Ddzqv | Ycj | $30.2 Bil | |||
| DexCom Inc
DXCM
| Jcgdymfls | Zrxcf | $27.3 Bil | |||
| Steris PLC
STE
| Rnhfzlzb | Wjypl | $22.8 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Dfxfgmprh | Pkh | $21.3 Bil | |||
| Insulet Corp
PODD
| Xrdkkzzng | Tmzfhs | $16.1 Bil |
United States